Effect of multisite radiofrequency ablation on porcine renal function.

BACKGROUND AND PURPOSE: The acute and long-term effects of radiofrequency ablation (RFA) on kidney function have not been well studied. The functional change when RFA is used in combination with renal ischemia is likewise unknown. Our goal was to determine the change in renal function caused by various volumes of RFA on a porcine kidney model and the effect cold ischemia had on the results. MATERIALS AND METHODS: Twenty-two female pigs with solitary kidneys underwent various volumes of RFA both with and without cold ischemia. Animals were divided into control, 10%, 15%, and 20% ablation of the total kidney volume. Measurements of creatinine were obtained for 2 weeks. RESULTS: In the nonischemic group, the mean acute (day 1-3) creatinine changes in control, 10%, 15%, and 20% ablations were 0.6, 2.4, 1.7, and 2.6 mg/dL, respectively. In the cold-ischemia group, the mean acute creatinine changes were 0.85, 2.33, 3.3, and 3.75 mg/dL, respectively. Regression line analysis demonstrated a positive linear relationship in both groups. Fourteen-day mean creatinine changes for the nonischemic group were similar to those in the control animals and did not show a correlation with ablation volume. The mean creatinine changes at 14 days in the cold-ischemia group showed a positive linear correlation with ablation volume. CONCLUSIONS: The volume of RFA correlates with an acute change in renal function in the porcine model for both nonischemic and cold-ischemia groups. This study may help predict the extent of acute renal dysfunction in patients undergoing RFA for large or multiple renal masses. These results also suggest renal function may recover after nonischemic RFA.

Efficacy and safety of fast-track recovery strategy for patients undergoing laparoscopic nephrectomy.

BACKGROUND AND PURPOSE: Factors that adversely affect early recovery after major laparoscopic procedures include ileus, pain, nausea, emesis, and fatigue. The objective of this randomized controlled study was to evaluate the impact of a multimodal fast-track (FT) rehabilitation program on recovery and length of hospital stay after laparoscopic nephrectomy. PATIENTS AND METHODS: Thirty patients undergoing laparoscopic nephrectomy received either conventional care (control) or an FT recovery program. All patients received a standardized anesthetic technique and patient- controlled analgesia (morphine) for postoperative pain control. In the FT group, patients received premedication with rofecoxib and ranitidine, local anesthesia was administered at the ports and renal fosa during surgery, and postoperative non-opioid analgesic and gastrokinetic drugs were administered as part of an early enteral nutrition and mobilization program. During the postoperative period, pain and nausea were assessed at specific time intervals. In addition, recovery room and hospital discharge times, the need for rescue analgesics and antiemetics, patient satisfaction with pain management and quality of recovery, and side effects were recorded daily for 3 days after surgery. Patients were discharged home when they met previously defined discharge criteria. RESULTS: The FT group was discharged earlier from the recovery room (74+/-23 v 103+/-47 minutes) and the hospital (41+/-11 v 59+/-11 hours). Pain and nausea scores were consistently lower in the FT group during the first 48 hours after surgery. In addition, the requirement for antiemetic rescue therapy during the first 24 hours was reduced in the FT group (15% v 58%). The FT group also received less morphine during the first 2 postoperative days (14+/-16 v 40+/-24 mg). Finally, patient satisfaction with postoperative pain control was significantly higher in the FT group. CONCLUSIONS: A multimodal approach to minimizing postoperative side effects led to a reduced recovery room and hospital stay, as well as better pain control and patient satisfaction after laparoscopic nephrectomy.

Cytokine response to surgical stress: comparison of pure laparoscopic, hand-assisted laparoscopic, and open nephrectomy.

BACKGROUND AND PURPOSE: Laparoscopic surgery has been shown to induce less immune suppression than open surgery, presumably because there is less tissue trauma, a factor that may impact oncologic-disease control. The objective of this study was to compare the cytokine and stress response associated with pure laparoscopic, hand-assisted laparoscopic (HAL), and open nephrectomy. MATERIAL AND METHODS: Fifteen female farm pigs (45-50 kg) underwent transperitoneal laparoscopic, handassisted (HAL), or open nephrectomy (N = 5 in each group). At 1, 4, 24, and 48 hours post-nephrectomy, blood and peritoneal fluid samples were collected for measurement of tumor necrosis factor (TNF) alpha, interleukin (IL)-1beta, and IL-6 using enzyme-linked immunosorbent assay (ELISA) techniques. Body temperature and serum glucose and cortisol were also measured. RESULTS: No evidence of perioperative infection was detected in any animal through temperature and glucose monitoring. Operating time and blood loss were comparable among the three groups. Peak serum cortisol concentrations were significantly higher in the HAL group than in the pure laparoscopic group at 24 hours (P = 0.02). Serum TFNalpha concentrations were significantly lower in the pure laparoscopy group (40 +/- 6 pg/mL) than in the HAL and open-nephrectomy groups (81 +/- 6 pg/mL and 83 +/- 17 pg/mL, respectively; P < 0.05), although no differences between groups were found in the serum IL-1beta and IL-6 concentrations. Peritoneal IL-1beta was significantly higher in the HAL than in the open-nephrectomy group (2993 +/- 507 pg/mL and 733 +/- 185 pg/mL, respectively; P = 0.05). Peritoneal IL-6 was significantly lower in the pure laparoscopy group (694 +/- 234 pg/mL) than in the open-surgery group (1668 +/- 312 pg/mL) (P = 0.04). CONCLUSION: Pure laparoscopic surgery in pigs elicits a less-robust cytokine response than HAL or open nephrectomy with respect to serum TNFalpha and peritoneal IL-6 concentrations, perhaps reflecting less impairment of the immune system. Clinical confirmation is required, and the implications with regard to oncologic tumor surveillance in humans require further study.

Short-term efficacy of temperature-based radiofrequency ablation of small renal tumors.

OBJECTIVES: To present our experience using radiofrequency ablation (RFA) for the treatment of small renal tumors. Our objective was to assess the short-term (1 to 3 years) oncologic efficacy of RFA. METHODS: Consecutive renal tumors treated since May 2001 with a minimal follow-up of 6 months were included. Patients were treated with a temperature-based radiofrequency generator and were followed up with serial imaging at 6 weeks, 3 and 6 months, and every 6 months thereafter. RESULTS: A total of 109 small renal tumors (91 patients) were treated with computed tomography-guided percutaneous RFA (n = 63) or laparoscopic RFA (n = 46). The mean tumor size was 2.4 cm (range 0.8 to 4.7). The initial ablation was successful in 107 (98%) of 109 tumors. The two incomplete ablations were successfully re-ablated. Of the 60 patients with at least 1 year of follow-up, 60% had biopsy proven renal cell carcinoma (an additional 24% had no tissue diagnosis). In this group, one local recurrence (1.7%) was detected during a mean follow-up of 19.4 months (range 12 to 33), and in those with known renal cell carcinoma, none had evidence of distant progression (0%). The local recurrence was successfully re-ablated such that all 109 cases had no clinical or radiographic evidence of disease at last follow-up. Three patients died of causes unrelated to cancer. CONCLUSIONS: The results of our study have shown that in the short term, RFA appears to be a reasonable therapeutic nephron-sparing approach for treating select patients with small renal tumors. The cancer control appears adequate to date, but longer follow-up is necessary before widespread application.

Contrast-enhanced ultrasound evaluation of radiofrequency ablation of the kidney: reliable imaging of the thermolesion.

BACKGROUND AND PURPOSE: Radiofrequency ablation (RFA) is limited by the inability to monitor progression of the thermal lesion. Contrast-enhanced ultrasonography (CEUS) imaging has considerable potential as a monitoring modality for RFA. We report our experience using CEUS to evaluate the lesion produced by RFA in a porcine model. MATERIALS AND METHODS: Five pigs underwent laparoscopic RFA twice, spaced by a 1-week interval. Post- RFA ultrasound imaging was performed transcutaneously immediately after ablation. The kidneys were assessed for a contrast void corresponding to the ablated tissue. The kidneys were then harvested and the gross RFA lesions measured to compare lesion size with that measured using CEUS. RESULTS: A clear lesion was identified at the site of each RFA application. As measured by CEUS, the acute lesions averaged 1.8 +/- 0.4, 1.7 +/- 0.4, and 1.8 +/- 0.3 cm in length, height, and width, respectively, compared with 2.0 +/- 0.5, 1.8 +/- 0.4, and 1.9 +/- 0.3 cm, respectively, by measurement in the gross specimen (P = 0.33, 0.13, and 0.44, respectively). At 1 week, the CEUS-measured dimensions of the lesions were 2.7 +/- 0.5, 2.6 +/- 0.6, and 2.6 +/- 0.6 cm, and the gross measurements of the lesion were 2.7 +/- 0.4, 2.7 +/- 0.9, and 2.6 +/- 0.4 cm (P = 0.75, 0.92, and 0.40, respectively). CONCLUSIONS: Contrast-enhanced ultrasonography appears to be an accurate modality for immediate monitoring of RFA defects. Further study is necessary to assess the clinical utility of CEUS for monitoring RFA of small renal lesions.

Defining the complications of cryoablation and radio frequency ablation of small renal tumors: a multi-institutional review.

PURPOSE: Ablative treatments (cryoablation or radio frequency ablation) for renal cell carcinoma aim to decrease morbidity by treating renal tumors in situ, eliminating the need for extirpation. These technologies have potential for complications previously unassociated with renal tumor treatment. We identified complications associated with percutaneous and laparoscopic ablative treatment of renal tumors. MATERIALS AND METHODS: Groups at medical centers with reported experience with ablation of renal tumors were invited to participate in this study. Each group submitted retrospective data regarding overall ablative treatment experience and associated complications. For each incident the nature of the complication, its associated morbidity, the necessity and nature of any subsequent interventions, and the final patient outcome were evaluated. Complications were divided into minor and major categories. Data were collected from groups at 4 institutions with a combined experience of 271 cases. Of these cases 139 were cryoablation and 133 were radio frequency ablation. There were 181 procedures performed percutaneously and 90 performed laparoscopically. RESULTS: A total of 30 complications occurred (11.1%) with 5 major (1.8%) and 25 minor (9.2%) complications, and 1 death (0.4%). Overall 26 of the 30 complications (86.7%) were directly attributable to the ablation procedure. The most common complication was pain or paraesthesia at the probe insertion site. CONCLUSIONS: Ablation technologies appear to have a low complication profile when used to treat small renal tumors. The majority of complications are minor and require observation only. Further study and followup are necessary to determine long-term oncological efficacy.

The radiographic evolution of radio frequency ablated renal tumors.

PURPOSE: Radio frequency ablation (RFA) of renal tumors is a relatively new technology. Few groups are familiar with the posttreatment appearance of these lesions and how they differ from cryoablated renal masses. We describe the evolution of the appearance of these lesions on followup contrast enhanced (CE) computerized tomography (CT). METHODS AND MATERIALS: A total of 64 consecutive renal tumors treated with RFA from April 2000 to September 2003 for which posttreatment CE-CT was done were included in this study. CE-CT was reviewed at 6 weeks, 3 months, 6 months and every 6 months thereafter to determine the characteristic features and evolution of these lesions. RESULTS: Renal tumors were treated with CT guided percutaneous (34), laparoscopic (28) or open (2) RFA. At a median followup of 13.7 months (range 6 weeks to 29 months) 62 RFA lesions demonstrated an absence of contrast enhancement on CE-CT. Treated endophytic tumors developed a low density, nonenhancing, wedge-shaped defect with fat infiltration seen between the ablated tissue and normal parenchyma. Treated exophytic tumors retained a configuration similar to that of the original with a lack of contrast enhancement and minimal shrinkage. Percutaneous treated lesions developed a peritumor scar or halo that demarcated ablated and nonablated tissue (perirenal fat). Persistent tumor was marked by contrast enhancement within the ablation borders of the original mass in 1 case, whereas tumor recurred after initial successful ablation with an enhancing nodule in 1. CONCLUSIONS: The radiographic features and evolution of radio frequency ablated renal tumors are unique. Successfully treated tumors demonstrated no contrast enhancement, minimal shrinkage and occasional retraction from normal parenchyma by fat infiltration.

Development of a renal tumor mimic model for learning minimally invasive nephron sparing surgical techniques.

PURPOSE: New laparoscopic partial nephrectomy and tumor ablation techniques are continuously being developed and evaluated in large animal models. However, to our knowledge no reliable renal tumor model exists to evaluate procedure efficacy. We developed and assessed the reliability of a tumor mimic model to serve as a training tool for minimally invasive kidney surgery. MATERIALS AND METHODS: An agarose based model was created using a mixture of 3% agarose, 3% cellulose, 7% glycerol and 0.05% methylene blue. It is liquid when heated, but solidifies after cooling to physiological temperatures. The agar was injected (0.7 cc) into porcine renal parenchyma to make endophytic or completely intraparenchymal lesions. Three-dimensional ultrasound images of the lesions were obtained during initial development to ensure spherical lesions. A group of 20 lesions was initially placed in an ex vivo setting to assess size consistency and define baseline impedance characteristics. An additional 20 tumor mimics each were established in a laparoscopic model in a laparoscopic box trainer and an in vivo laparoscopic model. They were ablated with a temperature based radio frequency generator to assess impedance characteristics but the efficacy of ablation was not assessed. The in vivo model consisted of placing the agar lesion percutaneously under direct laparoscopic vision. RESULTS: The agarose mixture was easily injected and readily visible on ultrasound as hyperechoic distinct lesions. Lesions had a mean size of 10.8 +/- SD 1.3 mm on ultrasound and 10.9 +/- 1.2 mm grossly. The impedance of normal renal parenchyma and unablated lesions was similar. Mean lesion size in the ex vivo model after radio frequency ablation was 9.8 +/- 2.0 mm on ultrasound, which was similar to the gross mean lesion size of 9.7 +/- 1.0 mm. Similar results were obtained for the in vivo model with a mean size of 10.1 +/- 2.1 and 10.4 +/- 1.5 mm, respectively. The lesions were easily identified grossly as blue solid lesions that replaced renal parenchyma. CONCLUSIONS: The described renal tumor mimic model reproducibly creates ex vivo and in vivo porcine kidney lesions. Lesion size and impedance do not change with the application of radio frequency energy. This model should be a valuable adjunct in the development, assessment and teaching of novel, nephron sparing, minimally invasive surgical techniques.

The use of shock wave lithotripsy for renal calculi.

PURPOSE OF REVIEW: Shock wave lithotripsy has been considered a mainstay of therapy for renal calculi for the last 20 years. Shock wave lithotripsy is noninvasive and requires the least anesthesia of the treatment modalities for treatment of renal calculi and therein lies its popularity. In the last decade, however, there have been changes in thinking regarding methods of patient selection for shock wave lithotripsy, changes in the technique of the existing shock wave lithotriptors and new technologies designed to increase the efficacy of shock wave lithotriptors. RECENT FINDINGS: New studies have shown that shock wave lithotripsy may be less effective than other modalities for treating lower pole stones. Other existing technologies, such as computerized tomography, are being used to more effectively select patients for shock wave lithotripsy. Ongoing studies are evaluating changing the shock wave rate to increase stone fragmentation. In addition, efforts are being made to improve lithotripsy by designing more effective lithotriptors. SUMMARY: Shock wave lithotripsy has become a widely used modality for treating renal calculi due to its noninvasive nature and ease of application. Although success rates are reasonable, there is room for improvement. With appropriate patient selection, significant improvements in stone-free rates may be achieved. It is anticipated that, with further research, improvements in lithotriptor design will result in higher treatment success rates with reduced renal trauma and improved patient comfort.

Complications of ureteroscopy.

Ureteroscopy has undergone a dramatic evolution over the last two decades. Although ureteroscopic injury is the most common cause of ureteral trauma because of the large number of ureteroscopic procedures performed, improvements in instrumentation and technique have resulted in a reduced incidence of serious complications. Despite significant technologic advances, however, surgical misadventures still occur, some of which have lasting consequences. Careful attention to instrument selection and surgical technique are critical to reduce untoward events related to ureteroscopy. As such, adverse sequelae associated with ureteroscopy should be related to the underlying pathology itself rather than to the treatment.

Radiofrequency ablation of small renal tumors.

Technological improvements have led to increased diagnosis of small renal tumors and to the development of minimally invasive treatments for these tumors. As a minimally invasive ablative treatment, radiofrequency ablation shows promise as a therapeutic option for selected patients. By creating heat using radiofrequency waves, radiofrequency ablation leads to controlled thermal ablation within the target tissue. Experimental studies have shown radiofrequency ablation to be safe and reproducible. Clinical studies are ongoing but early evidence suggests that radiofrequency ablation is safe and oncologic results are encouraging. With further development of monitoring techniques and additional maturation of oncologic data, radiofrequency ablation may become a standard treatment option for patients with small renal tumors.

Assessment of basic human performance resources predicts the performance of virtual ureterorenoscopy.

PURPOSE: Regardless of training, innate ability may influence the acquisition of endoscopic skills. Until recently objective methods to assess innate ability have not been available. We compared objective measures of human basic performance resources (BPRs) using nonlinear causal resource analysis (NCRA) and expert rated endoscopic performance of medical students on a virtual reality (VR) simulator. MATERIALS AND METHODS: BPRs were measured in 18 medical students (group 1) using 13 validated tests. BPR results were compared to the results of ureteroscopic skills assessment on the VR simulator. An NCRA model was devised to predict performance based on BPRs and the limiting performance resource (LPR). The same BPRs were measured in a second group of 14 medical students (group 2). Using the model created from group 1 performance of VR ureterorenoscopy was predicted based on LPR for each student in group 2. Predicted performance was compared to rated performance. RESULTS: The average difference in score between 2 expert raters was 7.2%. The average difference in predicted score based on the NCRA model and rated score was only 8.0%. In 9 of the 14 group 2 subjects (63%) the performance prediction by NCRA was in excellent agreement (+/-10%) with the expert rating on the VR simulation. NCRA over predicted performance in 2 subjects (14%) and under predicted performance in 3 (21%). CONCLUSIONS: Objective prediction of ureteroscopic performance in the VR environment using LPRs (measures of innate ability) for each subject is possible and practical using new measurement and modeling methods. The selection of surgical candidates, training and the educational curriculum could be impacted.

The effects of radio frequency ablation on renal function and blood pressure.

PURPOSE: Radio frequency ablation (RFA) is evolving as a nephron sparing treatment alternative for select patents with small renal tumors. The impact of ablated tissue on the remaining kidney parenchyma is unknown. To assess this impact we evaluated pretreatment and posttreatment serum creatinine (sCr), and blood pressure of patients treated with RFA with at least 6 months of followup. MATERIALS AND METHODS: From our series of 69 tumors treated with RFA 25 patients with a total of 26 tumors and a minimum 6-month followup were identified. RFA was delivered percutaneously or laparoscopically depending on tumor location and patient preference. Blood pressure measurements and sCr levels were obtained at preoperative and postoperative office visits. Values for preoperative and postoperative systolic blood pressure, diastolic pressure and sCr were each compared. Estimated creatinine clearance was calculated for each patient before and after treatment, and compared. RESULTS: No patient experienced new onset hypertension or worsening of existing hypertension. Likewise no changes in mean sCr and estimated creatinine clearance were observed. CONCLUSIONS: Treatment with RFA does not appear to have an effect on renal function or blood pressure. RFA appears to be a medically safe therapy for patients with small renal tumors.

Radiofrequency interstitial tumor ablation: dry electrode.

With the shift in the treatment of small renal tumors from radical extirpative surgery to nephron-sparing approaches, dry-electrode radiofrequency ablation (RFA) has emerged as one potential modality. This application of RF energy leads to the production of heat within the treatment zone secondary to the native impedance of living tissue. Animal studies and human clinical series have demonstrated that RFA can create controlled, targeted, reproducible, and lethal lesions. Most clinical series have reported promising results, although some authors question the totality of tumor destruction by RFA. With time, the efficacy of RFA, as measured by patient survival, will be determined. Once this is known, RFA may be compared with other therapeutic modalities for small renal tumors to determine its place.

Cryoablation of renal and prostate tumors.

During the past decade, cryoablation has been applied to benign and malignant conditions within the prostate and kidney. The essence of cryosurgery lies in producing temperatures low enough to cause necrosis in target tissues while avoiding lethal conditions in healthy peripheral tissues. It works by two main mechanisms: (1) at the cellular level via solute damage and intracellular ice formation; and (2) at the vascular level as a result of thrombosis and subsequent coagulative and ischemic necrosis. Investigation of cryoablation for renal tumors began in 1964, and by the 1990s, attention was turning to its use as a means of treating renal tumors. Modern renal cryosurgery is applied using minimally invasive techniques. Cryotherapy was first applied in the prostate in 1966 and soon thereafter was used to treat prostate cancer. Today, prostate cryosurgical techniques employ ultrasound monitoring and urethral warming to minimize urethral and rectal complications.

Laparoscopic donor nephrectomy at a low volume living donor transplant center: successful outcomes can be expected.

PURPOSE: Concern has been raised about possible increased morbidity associated with laparoscopic donor nephrectomy (LDN) during the learning curve of the procedure and at centers with a low volume of living donors. We evaluated the safety and success of LDN at a low volume living donor transplant center with a skilled laparoscopic urologist and experienced renal transplant team. MATERIALS AND METHODS: We reviewed the records of all patients who underwent LDN at our institution. A single surgeon skilled in laparoscopy (JAC) performed all LDNs. Patient demographics, operative reports, complications and recipient outcomes were evaluated. RESULTS: A total of 17 LDNs were performed between January 2000 and September 2002. There was 1 elective conversion to an open procedure for kidney harvest due to complex hilar anatomy. Only 1 minor complication occurred (wound seroma) and 1 donor had creatinine persistently elevated to 1.9 mg/dl (normal 0.6 to 1.2). Mean operating room time, estimated blood loss and hospital stay were 250 minutes, 188 ml and 2.5 days, respectively. Recipient creatinine had a nadir mean of 1.2 mg/dl and a 90-day postoperative mean of 1.6 mg/dl. One recipient eventually lost the graft due to recurrent disease. CONCLUSIONS: LDN can be performed safely and efficiently at low volume transplant centers with a skilled laparoscopist and experienced renal transplant team. Laparoscopic skills developed during similar procedures, such as laparoscopic radical and partial nephrectomy, minimize the learning curve and morbidity of LDN to produce results consistent with those in the published literature.

Nephrectomy after radiofrequency ablation-induced ureteropelvic junction obstruction: potential complication and long-term assessment of ablation adequacy.

Little information is available concerning the morbidity of radiofrequency ablation (RFA) or the evolution of an RFA lesion over time. We report our findings in a kidney removed 1 year after RFA of a 2.3-cm renal tumor. After RFA, the patient experienced flank pain, followed by hydronephrosis, ureteropelvic junction obstruction, and eventual loss of function in the treated kidney. Nephrectomy revealed no residual renal cell carcinoma. RFA can completely destroy renal cell carcinoma in situ without histologic evidence of persistence or recurrence for up to 1 year after treatment. Care must be taken to avoid concurrent damage to the collecting system.

University of Wisconsin experience using the Doli S lithotriptor.

OBJECTIVES: To present our initial results using the Dornier Doli S lithotriptor with the 220 electromagnetic shock wave emitter to treat urinary calculi. At present, there is no published report of the efficacy of this instrument in service in the United States. METHODS: We retrospectively reviewed the outcome of shock wave lithotripsy in 270 consecutive patients with solitary renal and/or ureteral stones treated from September 1998 to October 2001 with the Dornier Doli S lithotriptor. Data were collected with respect to stone size, location, and fragmentation. RESULTS: Of the 270 patients treated, 204 had renal stones and 66 had ureteral stones. All patients had solitary stones. The renal stones averaged 9.7 mm in size (range 4 to 26). The ureteral stones averaged 7.8 mm (range 4 to 17). Of the renal stones, 51% were located in the renal pelvis, with 18%, 5%, and 25% located in the upper, middle, and lower poles, respectively. Of the ureteral stones, 68% were located in the proximal ureter, with 14% and 18% in the mid and distal ureter, respectively. In the renal group, 176 (86%) of 204 patients achieved clinical success. Of these patients, 148 were stone free (73%) and 28 had residual fragments less than 4 mm in size (14%). In the ureteral group, 52 (79%) of 66 patients achieved clinical success. Of these patients, 50 were stone free (76%) and 2 (3%) patients had fragments less than 4 mm in size. Thirteen (6%) of 204 patients in the renal group required retreatment. Four (6%) of 62 patients in the ureteral group required retreatment. Of the patients in whom treatment failed and who had stone analysis, 16 (76%) of 21 had stones composed of predominantly calcium oxalate monohydrate. Four patients developed steinstrasse. Two were treated with retrograde stent placement, and the other two with placement of percutaneous nephrostomy. One patient developed a known perinephric hematoma but did not require a blood transfusion. CONCLUSIONS: Shock wave lithotripsy using the Doli S in appropriately selected patients is an effective instrument for treating urinary calculi throughout the urinary tract.

Resection of isolated fossa recurrence of renal-cell carcinoma after nephrectomy using hand-assisted laparoscopy.

A 72-year-old woman with a body mass index of 33.6 had an apparently isolated renal fossa recurrence of a Grade II, Stage T(3) renal-cell carcinoma. The lesion was resected using hand-assisted laparoscopy with rapid recovery and good short-term results.